收藏 分享(赏)

03-硕士研究生课-现代分子生物学-基础知识-3-细胞信号转导-李恩民.ppt

上传人:天天快乐 文档编号:1216778 上传时间:2018-06-18 格式:PPT 页数:29 大小:3.35MB
下载 相关 举报
03-硕士研究生课-现代分子生物学-基础知识-3-细胞信号转导-李恩民.ppt_第1页
第1页 / 共29页
03-硕士研究生课-现代分子生物学-基础知识-3-细胞信号转导-李恩民.ppt_第2页
第2页 / 共29页
03-硕士研究生课-现代分子生物学-基础知识-3-细胞信号转导-李恩民.ppt_第3页
第3页 / 共29页
03-硕士研究生课-现代分子生物学-基础知识-3-细胞信号转导-李恩民.ppt_第4页
第4页 / 共29页
03-硕士研究生课-现代分子生物学-基础知识-3-细胞信号转导-李恩民.ppt_第5页
第5页 / 共29页
点击查看更多>>
资源描述

1、1,细胞信号转导,2,3,磷酸化共价修饰代谢途径中的关键酶 糖原合成酶:抑制糖原合成 糖原磷酸化酶b激酶 糖原磷酸化酶a :促进糖原分解 特点:一 被磷酸化共价修饰的蛋白发生生物效应的空间位 置位于胞浆。 二 调节速度相对快。,4,5,cell membrane,Gs/i,cAMP,PKAc,P,1,AC,R,下丘脑的释放激素,ATP,TGACGTCA,gene,CREB,P,CREB,RNA,肾上腺素,胰高血糖素,垂体促激素,抗利尿激素,绒毛膜促性腺激素,甲状旁腺素,大多数肽类激素,AMP,PDE,+,_,茶碱,胰岛素Ca2+CaM,儿茶酚胺,2受体,Gi,儿茶酚胺,受体,生长抑素,2受体,

2、Gi,cell in,cell out,TPK,R,信息物质-X,,,信息物质-X,信息物质-Y,信息物质-Y ?,生长因子,癌蛋白,细胞因子,cAMP介导的信息跨膜传递,生化效应:靶蛋白丝/苏氨酸的磷酸化 抑制糖原合成,促进糖原分解 促进脂肪分解,抑制脂肪酸合成 去除对相关基因转录的阻遏,并同时加速转录与翻译过程 使心肌肌原蛋白易于结合Ca2+,加速心肌肌浆网膜蛋白摄Ca2+ 改变微管蛋白的构象与功能,影响细胞分泌 影响细胞膜蛋白的构象,改变膜对水和离子的通透性,胰岛素,Gi,抗血管紧张素,Gi,促肾上腺皮质激素,Mg2+,ATP,6,7,8,9,10,11,Src Homology dom

3、ain, SH1, SH2 and SH3,SH1: Tyrosine kinase domainSH2: recognizes and binds with high affinity to peptide motifs containing a phosphotyrosine (pTyr) and involves Signal transduction.SH3: binds to proline-rich ligands with moderate affinity and selectivity, preferentially to PxxP motifs; they play a r

4、ole in the regulation of enzymes by intramolecular interactions, changing the subcellular localization of,12,For examples,SH3,SH3,SH3,SH3,SH3,SH2,SH2,SH2,SH2,SH2,SH2,SH1, tyrosine kinase,Phospholipase C,Phospholipase C,GTPase activating protein,Src,Grb2,GAP,PLC 1,13,1 ME AIAKY*DF*KATADDE*LS1FKRGDILK

5、VLNEECDQN 36 W*YKAELNGKDGFIP1*KNY*IE MKP2H P3WFFGKIP4RAKA 71 EEMLS2KQRHDGAFLIRES3ES4AP5GDFS5LS6VKFGNDV106 QHFKVLRDGAGKYFLWVVKFNS7LNELVDYHRS8TS9VS10R143 NQQIFLR DIEQVP6QQP7T YVQALF*DF*DP8QEDGE*LGFRRG181 DFIHVMDNS11DP9NW*WKGACHGQTGMFP10*RNY*VTP11 VNRNV,Primary structure of Grb2 protein,SH3-3,SH3-2,SH2

6、+7,3-54,59-149,160-212,+2,* proline-rich ligand binding site,14,ME A3IAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIE54 MKP57H P59WFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLR149 DIEQVP155QQP158T Y160VQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTP

7、212 VNRNV,15,16,Molecular Weight: 529.481 g/molMolecular Formula: C21H32N5O9PHydrogen Bond Donor Count: 7Hydrogen Bond Acceptor Count: 9Rotatable Bond Count: 14 , Charge: 0 Tautomer Count: 32, Heavy Atom Count: 36 Topological Polar Surface Area: 240XLogP: -3.3, Exact Mass: 529.194MonoIsotopic Mass:

8、529.194Complexity: 855, Isotope Atom Count: 0Defined Atom StereoCenter Count: 3Undefined Atom StereoCenter Count: 0Defined Bond StereoCenter Count: 0Undefined Bond StereoCenter Count: 0Covalently-Bonded Unit Count: 1,IUPAC Name: 4-(2R)-2-(2S)-1-(2S)-1,4-diamino-1,4-dioxobutan-2-ylamino-3-methyl-1-ox

9、obutan-2-ylcarbamoyl-4-methylamino-4-oxobutylphenyl dihydrogen phosphateCanonical SMILES: CC(C)C(C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C(CC1=CC=C(C=C1)OP(=O)(O)O)CC(=O)NCIsomeric SMILES: C(C)CH(C(=O)NCH(CC(=O)N)C(=O)N)NC(=O)CH(CC1=CC=C(C=C1)OP(=O)(O)O)CC(=O)NCInChI: InChI=1/C21H32N5O9P/c1-11(2)18(21(31)25-15

10、(19(23)29)10-16(22)27)26-20(30)13(9-17(28)24-3)8-12-4-6-14(7-5-12)35-36(32,33)34/h4-7,11,13,15,18H,8-10H2,1-3H3,(H2,22,27)(H2,23,29)(H,24,28)(H,25,31)(H,26,30)(H2,32,33,34)/t13-,15+,18+/m1/s1/f/h24-26,32-33H,22-23H2,17,Molecular Weight: 46.0254 g/molMolecular Formula: CH2O2Hydrogen Bond Donor Count:

11、 1Hydrogen Bond Acceptor Count: 2Rotatable Bond Count: 0Topological Polar Surface Area: 37.3XLogP: -0.3Exact Mass: 46.0055MonoIsotopic Mass: 46.0055Heavy Atom Count: 3Charge: 0Complexity: 10.3Isotope Atom Count: 0Defined Atom StereoCenter Count: 0Undefined Atom StereoCenter Count: 0Defined Bond Ster

12、eoCenter Count: 0Undefined Bond StereoCenter Count: 0Covalently-Bonded Unit Count: 1IUPAC Name: formic acidCanonical SMILES: C(=O)OInChI: InChI=1/CH2O2/c2-1-3/h1H,(H,2,3)/f/h2H,18,19,Grb2 binds glycerol,glycerol,20,SH3 of Grb2,21,Grb2, N-Terminal Sh3 DomainComplexed With Sos-A Peptide (Nmr, 29 Struc

13、tures),Sos-A: SPLLPKLPPKTYKRE(Mouse )(Homo sapiens, Sos-A : SPHLPKLPPKTYKRE),SH3: GSRRASVG SMEAIAKYDFKATA D DELSFKR G DILKVL NEECDQ NWYKAELNGKDFIPK N YIEMKP HPEFIVTD,22,Sos-A: SPLLPK6LPPK10TYKRE,SH3:GSRRASVGSMEAIAKYDFKATAD23D24E25*LSFKRGDILKVLNEECD42QNWYKAELNGKDFIPKNYIEMKPHPEFIVTD,- D23D24E25*,+ K6,

14、+ K10,- D42,23,24,25,MQQAPQPYEFFSEENSPKWRGLLVSALRKVQVQVHPTLSANEESLYYIEELIFQLLNKLCMAQPRTVQDVEERVQKTFPHPIDKWAIADAQSAIEKRKRRNPLLLPVDKIHPSLKEVLGYKVDYHVSLYIVAVLEYISADILKLAGNYVFNIRHYEISQQDIKVSMCADKVLMDMFDQDDIGLVSLCEDEPCSSGELNYYDLVRTEIAEERQYLRELNMIIKVFREAFLSDRKLFKPSVYEKIFSNISDIHELTVKLLGLIEDTVEMTDESSPHPLAGS

15、CFEDLAEEQAFDPYETLSQDILSPEFHEHFNKLMARPAVALHFQSIADGFKEAVRYVLPRLMLVPVYHCWHYFELLKQLKACSEEQEDRECLNQAITALMNHQGSMDRIYKQYSPRRRPGDPVCPFYSHQLRSKHLAIKKMNEIQKNIDGWEGKDIGQCCNEFIMEGPLTRIGAKHERHIFLFDGLMISCKPNHGQTRLPGYTSAEYRLKEKFVMRKIQICDKEDTCEHKHAFELVSKDENSIIFAAKSAEEKNNWMAALISLHYRSTLDRMLDSVLLKEENEQPLRLPSPEVYRFVVKD

16、SEENIVFEDNLQSRSGIPIIKGGTVVKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLLIERFEIPEPEPTDADKLAIEKGEQPISADLKRFRKEYVQPVQLRVLNVFRHWVDHHYYDFERDLELLERLESFISSVRGKAMKKWVESIAKIIRRKKQAQANGVSHNITFESPPPPIEWHISKPGQFETFDLMTLDPIEIARQLTLLESDLYRKVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVEAENFEERVAVLSRIIEILQVFQDLNNFNGVLEIVSAVNSV

17、SVYRLDHTFEALQERKRKILDEAVELSQDHFKKYLVKLKSINPPCVPFFGIYLTNILKTEEGNNDFLKRKGKDLINFSKRRKVAEITGEIQQYQNQPYCLRIEPDMRRFFENLNPMGSASEKEFTDYLFNKSLEIEPRNCKQPPRFPRKSTFSLKSPGIRPNTGRHGSTSGTLRGHPTPLEREPCKISFSRIAETELESTVSAPTSPNTP63STPPVSASSDLSVFLDVDLNSSCGSNSIFAPVLLPHSKSFFSSCGSLHKLSEEPLIPPPLPPRKKFDHDASNSKGNMKSDDDPPAIPP

18、RQPPPPKVKPRVPVPTGAFDGPLHSPPPPPPRDPLPDTPPPVPLRPPEHFINCPFNLQPPPLGHLHRDSDWLRDISTCPNSPSTPPSTPSPRVPRRCYVLSSSQNNLAHPPAPPVPPRQNSSPHLPKLPPKTYKRELSHPPLYRLPLLENAETPQ,SOS2(son of sevenless homolog 2, Homo sapiens)Proline rate: total, 9.3%(124); front part 1088 aa, 5.7%; back part 244 aa, 25.4%,26,Inosital trip

19、hosphate,Diacylglycerol,27,28,MADEEAEQERLSCGEGGCVAELQRLGERLQELELQLRESRVPAVEAATDYCQQLCQTLLEYAEKWKTSEDPLPLLEVYTVAIQSYVKARPYLTSECENVALVLERLALSCVELLLCLPVELSDKQWEQFQTLVQVAHEKLMENGSCELHFLATLAQETGVWKNPVLCTILSQEPLDKDKVNEFLAFEGPILLDMRIKHLIKTNQLSQATALAKLCSDHPEIGIKGSFKQTYLVCLCTSSPNGKLIEEISEVDCKDALEMICNLESEGDEK

20、SALVLCTAFLSRQLQQGDMYCAWELTLFWSKLQQRVEPSIQVYLERCRQLSLLTKTVYHIFFLIKVINSETEGAGLATCIELCVKALRLESTENTEVKISICKTISCLLPDDLEVKRACQLSEFLIEPTVDAYYAVEMLYNQPDQKYDEENLPIPNSLRCELLLVLKTQWPFDPEFWDWKTLKRQCLALMGEEASIVSSIDELNDSEVYEKVVDYQEESKETSMNGLSGGVGANSGLLKDIGDEKQKKREIKQLRERGFISARFRNWQAYMQYCVLCDKEFLGHRIVRHAQKHYKDGIYS

21、CPICAKNFNSKETFVPHVTLHVKQSSKERLAAMKPLRRLGRPPKITTTNENQKTNTVAKQEQRPIKKNSLYSTDFIVFNDNDGSDDENDDKDKSYEPEVIPVQKPVPVNEFNCPVTFCKKGFKYFKNLIAHVKGHKDNEDAKRFLEMQSKKVICQYCRRHFVSVTHLNDHLQMHCGSKPYICIQMKCKAGFNSYAELLTHRKEHQVFRAKCMFPKCGRIFSEAYLLYDHEAQHYNTYTCKFTGCGKVYRSQGELEKHLDDHSTPPEKVLPPEAQLNSSGDSIQPSEVNQNTAENIEKERS

22、MLPSENNIENSLLADRSDAWDKSKAESAVTKQDQISASELRQANGPLSNGLENPATTPLLQSSEVAVSIKVSLNQGIEDNFGKQENSTVEGSGEALVTDLHTPVEDTCNDLCHPGFQERKEQDCFNDAHVTQNSLVNSETLKIGDLTPQNLERQVNNLMTFSVQNQAAFQNNLPTSKFECGDNVKTSSNLYNLPLKTLESIAFVPPQSDLSNSLGTPSVPPKAPVQKFSCQVEGCTRTYNSSQSIGKHMKTAHPDQYAAFKMQRKSKKGQKANNLNTPNNGKFVYFLPSPVNSSNPFFTS

23、QTKANGNPACSAQLQHVSPPIFPAHLASVSTPLLSSMESVINPNITSQDKNEQGGMLCSQMENLPSTALPAQMEDLTKTVLPLNIDSGSDPFLPLPAESSSMSLFPSPADSGTNSVFSQLENNTNHYSSQIEGNTNSSFLKGGNGENAVFPSQVNVANNFSSTNAQQSAPEKVKKDRGRGPNGKERKPKHNKRAKWPAIIRDGKFICSRCYRAFTNPRSLGGHLSKRSYCKPLDGAEIAQELLQSNGQPSLLASMILSTNAVNLQQPQQSTFNPEACFKDPSFLQLLAENRSPAFLPNTF

24、PRSGVTNFNTSVSQEGSEIIKQALETAGIPSTFEGAEMLSHVSTGCVSDASQVNATVMPNPTVPPLLHTVCHPNTLLTNQNRTSNSKTSSIEECSSLPVFPTNDLLLKTVENGLCSSSFPNSGGPSQNFTSNSSRVSVISGPQNTRSSHLNKKGNSASKRRKKVAPPLIAPNASQNLVTSDLTTMGLIAKSVEIPTTNLHSNVIPTCEPQSLVENLTQKLNNVNNQLFMTDVKENFKTSLESHTVLAPLTLKTENGDSQMMALNSCTTSINSDLQISEDNVIQNFEKTLEIIKTAMNSQI

25、LEVKSGSQGAGETSQNAQINYNIQLPSVNTVQNNKLPDSSPFSSFISVMPTKSNIPQSEVSHKEDQIQEILEGLQKLKLENDLSTPASQCVLINTSVTLTPTPVKSTADITVIQPVSEMINIQFNDKVNKPFVCQNQGCNYSAMTKDALFKHYGKIHQYTPEMILEIKKNQLKFAPFKCVVPTCTKTFTRNSNLRAHCQLVHHFTTEEMVKLKIKRPYGRKSQSENVPASRSTQVKKQLAMTEENKKESQPALELRAETQNTHSNVAVIPEKQLVEKKSPDKTESSLQVITVTSEQCNTN

26、ALTNTQTKGRKIRRHKKEKEEKKRKKPVSQSLEFPTRYSPYRPYRC*VHQGC*FAAFTIQQNLILH*YQAVH*KSDLPAFSAEVEEESEAGKESEETETKQTLKEFRCQVSDCSRIFQAITGLIQHYMKLHEMTPEEIESMTASVDVGKFPCDQLECKSSFTTYLNYVVHLEADHGIGLRASKTEEDGVYKCDCEGCDRIYATRSNLLRHIFNKHNDKHKAHLIRPRRLTPGQENMSSKANQEKSKSKHRGTKHSRCGKEGIKMPKTKRKKKNNLENKNAKIVQIEENKPYSLKRGKHVY

27、SIKARNDALSECTSRFVTQYPCMIKGCTSVVTSESNIIRHYKCHKLSKAFTSQHRNLLIVFKRCCNSQVKETSEQEGAKNDVKDSDTCVSESNDNSRTTATVSQKEVEKNEKDEMDELTELFITKLINEDSTSVETQANTSSNVSNDFQEDNLCQSERQKASNLKRVNKEKNVSQNKKRKVEKAEPASAAELSSVRKEEETAVAIQTIEEHPASFDWSSFKPMGFEVSFLKFLEESAVKQKKNTDKDHPNTGNKKGSHSNSRKNIDKTAVTSGNHVCPCKESETFVQFANPSQLQCSDNVKIVLDKNLKDCTELVLKQLQEMKPTVSLKKLEVHSNDPDMSVMKDISIGKATGRGQY,Zinc finger protein 292: 2723 aa, 305KD, pI 7.27, 67+,1,2,3,4,29,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 学术论文 > 毕业论文

本站链接:文库   一言   我酷   合作


客服QQ:2549714901微博号:道客多多官方知乎号:道客多多

经营许可证编号: 粤ICP备2021046453号世界地图

道客多多©版权所有2020-2025营业执照举报